119 related articles for article (PubMed ID: 37862431)
1. BCL6 promotes a stem-like CD8
Sun Q; Cai D; Liu D; Zhao X; Li R; Xu W; Xie B; Gou M; Wei K; Li Y; Huang J; Chi X; Wei P; Hao J; Guo X; Pan B; Fu Y; Ni L; Dong C
Sci Immunol; 2023 Oct; 8(88):eadh1306. PubMed ID: 37862431
[TBL] [Abstract][Full Text] [Related]
2. Bcl6 promotes follicular helper T-cell differentiation and PD-1 expression in a Blimp1-independent manner in mice.
Xie MM; Koh BH; Hollister K; Wu H; Sun J; Kaplan MH; Dent AL
Eur J Immunol; 2017 Jul; 47(7):1136-1141. PubMed ID: 28586108
[TBL] [Abstract][Full Text] [Related]
3. Differential Requirements for Tcf1 Long Isoforms in CD8
Gullicksrud JA; Li F; Xing S; Zeng Z; Peng W; Badovinac VP; Harty JT; Xue HH
J Immunol; 2017 Aug; 199(3):911-919. PubMed ID: 28652395
[TBL] [Abstract][Full Text] [Related]
4. BLIMP1 and NR4A3 transcription factors reciprocally regulate antitumor CAR T cell stemness and exhaustion.
Jung IY; Narayan V; McDonald S; Rech AJ; Bartoszek R; Hong G; Davis MM; Xu J; Boesteanu AC; Barber-Rotenberg JS; Plesa G; Lacey SF; Jadlowsky JK; Siegel DL; Hammill DM; Cho-Park PF; Berger SL; Haas NB; Fraietta JA
Sci Transl Med; 2022 Nov; 14(670):eabn7336. PubMed ID: 36350986
[TBL] [Abstract][Full Text] [Related]
5. Cutting Edge: Transcription Factor BCL6 Is Required for the Generation, but Not Maintenance, of Memory CD8
Liu Z; Guo Y; Tang S; Zhou L; Huang C; Cao Y; Huang H; Wu X; Meng D; Ye L; He H; Xie Z; Wu Y; Liu X; Zhou X
J Immunol; 2019 Jul; 203(2):323-327. PubMed ID: 31175159
[TBL] [Abstract][Full Text] [Related]
6. Bcl6 and Blimp1 reciprocally regulate ST2
Koh B; Ulrich BJ; Nelson AS; Panangipalli G; Kharwadkar R; Wu W; Xie MM; Fu Y; Turner MJ; Paczesny S; Janga SC; Dent AL; Kaplan MH
J Allergy Clin Immunol; 2020 Nov; 146(5):1121-1136.e9. PubMed ID: 32179158
[TBL] [Abstract][Full Text] [Related]
7. CD69 Imposes Tumor-Specific CD8+ T-cell Fate in Tumor-Draining Lymph Nodes.
Koyama-Nasu R; Kimura MY; Kiuchi M; Aoki A; Wang Y; Mita Y; Hasegawa I; Endo Y; Onodera A; Hirahara K; Motohashi S; Nakayama T
Cancer Immunol Res; 2023 Aug; 11(8):1085-1099. PubMed ID: 37216576
[TBL] [Abstract][Full Text] [Related]
8. The TCF1-Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemness.
Wu T; Ji Y; Moseman EA; Xu HC; Manglani M; Kirby M; Anderson SM; Handon R; Kenyon E; Elkahloun A; Wu W; Lang PA; Gattinoni L; McGavern DB; Schwartzberg PL
Sci Immunol; 2016 Dec; 1(6):. PubMed ID: 28018990
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral Tcf1
Siddiqui I; Schaeuble K; Chennupati V; Fuertes Marraco SA; Calderon-Copete S; Pais Ferreira D; Carmona SJ; Scarpellino L; Gfeller D; Pradervand S; Luther SA; Speiser DE; Held W
Immunity; 2019 Jan; 50(1):195-211.e10. PubMed ID: 30635237
[TBL] [Abstract][Full Text] [Related]
10. STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation.
Diehl SA; Schmidlin H; Nagasawa M; van Haren SD; Kwakkenbos MJ; Yasuda E; Beaumont T; Scheeren FA; Spits H
J Immunol; 2008 Apr; 180(7):4805-15. PubMed ID: 18354204
[TBL] [Abstract][Full Text] [Related]
11. Stem-like progenitor and terminally differentiated T
Zhou W; Kawashima S; Ishino T; Kawase K; Ueda Y; Yamashita K; Watanabe T; Kawazu M; Dansako H; Suzuki Y; Nishikawa H; Inozume T; Nagasaki J; Togashi Y
Cell Rep; 2024 Feb; 43(2):113797. PubMed ID: 38363680
[TBL] [Abstract][Full Text] [Related]
12. The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis.
Miyauchi Y; Ninomiya K; Miyamoto H; Sakamoto A; Iwasaki R; Hoshi H; Miyamoto K; Hao W; Yoshida S; Morioka H; Chiba K; Kato S; Tokuhisa T; Saitou M; Toyama Y; Suda T; Miyamoto T
J Exp Med; 2010 Apr; 207(4):751-62. PubMed ID: 20368579
[TBL] [Abstract][Full Text] [Related]
13. Bcl6 acts as an amplifier for the generation and proliferative capacity of central memory CD8+ T cells.
Ichii H; Sakamoto A; Kuroda Y; Tokuhisa T
J Immunol; 2004 Jul; 173(2):883-91. PubMed ID: 15240675
[TBL] [Abstract][Full Text] [Related]
14. Tumor-infiltrating CD62L+PD-1-CD8 T cells retain proliferative potential via Bcl6 expression and replenish effector T cells within the tumor.
Gong Y; Suzuki T; Kozono H; Kubo M; Nakano N
PLoS One; 2020; 15(8):e0237646. PubMed ID: 32845913
[TBL] [Abstract][Full Text] [Related]
15. Tumor immunogenicity dictates reliance on TCF1 in CD8
Escobar G; Tooley K; Oliveras JP; Huang L; Cheng H; Bookstaver ML; Edwards C; Froimchuk E; Xue C; Mangani D; Krishnan RK; Hazel N; Rutigliani C; Jewell CM; Biasco L; Anderson AC
Cancer Cell; 2023 Sep; 41(9):1662-1679.e7. PubMed ID: 37625402
[TBL] [Abstract][Full Text] [Related]
16. Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer.
Kim K; Park S; Park SY; Kim G; Park SM; Cho JW; Kim DH; Park YM; Koh YW; Kim HR; Ha SJ; Lee I
Genome Med; 2020 Feb; 12(1):22. PubMed ID: 32111241
[TBL] [Abstract][Full Text] [Related]
17. Bcl6 middle domain repressor function is required for T follicular helper cell differentiation and utilizes the corepressor MTA3.
Nance JP; Bélanger S; Johnston RJ; Hu JK; Takemori T; Crotty S
Proc Natl Acad Sci U S A; 2015 Oct; 112(43):13324-9. PubMed ID: 26460037
[TBL] [Abstract][Full Text] [Related]
18. TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8
Seo H; Chen J; González-Avalos E; Samaniego-Castruita D; Das A; Wang YH; López-Moyado IF; Georges RO; Zhang W; Onodera A; Wu CJ; Lu LF; Hogan PG; Bhandoola A; Rao A
Proc Natl Acad Sci U S A; 2019 Jun; 116(25):12410-12415. PubMed ID: 31152140
[TBL] [Abstract][Full Text] [Related]
19. TOX promotes the exhaustion of antitumor CD8
Wang X; He Q; Shen H; Xia A; Tian W; Yu W; Sun B
J Hepatol; 2019 Oct; 71(4):731-741. PubMed ID: 31173813
[TBL] [Abstract][Full Text] [Related]
20. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1
Moreno-Cubero E; Subirá D; Sanz-de-Villalobos E; Parra-Cid T; Madejón A; Miquel J; Olveira A; González-Praetorius A; García-Samaniego J; Larrubia JR
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
